Gail Boudreaux - 02 Mar 2026 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role
President and CEO, Director
Signature
/s/ Kathleen S. Kiefer, Attorney in fact
Issuer symbol
ELV
Transactions as of
02 Mar 2026
Net transactions value
$0
Form type
4
Filing time
04 Mar 2026, 16:56:45 UTC
Previous filing
18 Jul 2025
Next filing
13 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BOUDREAUX GAIL President and CEO, Director 220 VIRGINIA AVENUE, INDIANAPOLIS /s/ Kathleen S. Kiefer, Attorney in fact 04 Mar 2026 0001287920

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELV Common Stock Tax liability -6,713 -4.4% $294.07* 144,307 02 Mar 2026 Direct F1
transaction ELV Common Stock Award +16,153 +11% $0.000000* 160,460 02 Mar 2026 Direct F2
transaction ELV Common Stock Award +10,527 +6.6% $0.000000* 170,987 02 Mar 2026 Direct F3
transaction ELV Common Stock Tax liability -1,736 -1% $284.03* 169,251 03 Mar 2026 Direct F1
holding ELV Common Stock 60 02 Mar 2026 Shares Held in Spouse's Revocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELV Employee Stock Option (Right to Buy) Award +63,818 $0.000000* 63,818 02 Mar 2026 Common Stock 63,818 $294.07 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2 Represents restricted share units. Restrictions lapse as follows: 5,384 shares each on 3/2/2027 and 3/2/2028 and 5,385 shares on 3/2/2029.
F3 Represents performance based restricted share units. Restrictions lapsed on 3/2/2026.
F4 The option represents a right to purchase a total of 63,818 shares, and is exercisable in three annual installments, with one installment of 21,272 shares and two installments of 21,273 shares each, beginning on 3/2/2027, which is the one-year anniversary of the option grant date.